Chordia Therapeutics Inc (190A) Stock Price & News

All values in JPY	Aug 2025	Nov 2025	Feb 2026	May 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	299.45M	229.68M	280.65M	331.16M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	69.46M	76.58M	75.81M	76.81M
Operating expense	368.90M	306.26M	356.47M	407.97M
Total operating expenses	368.90M	306.26M	356.47M	407.97M
Operating income	-368.90M	-306.26M	-356.47M	-407.97M
Other non operating income	-13.68M	16.43M	18.16M	-2.17M
EBT including unusual items	-385.91M	-294.85M	-337.91M	-413.51M
EBT excluding unusual items	-385.91M	-294.85M	-337.91M	-413.51M
Income tax expense	605.00K	475.00K	475.00K	475.00K
Effective tax rate	-0.16%	-0.16%	-0.14%	-0.11%
Other operating expenses	-	-	-	-
Net income	-386.52M	-295.32M	-338.38M	-413.98M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-368.23M	-305.58M	-355.79M	-407.29M
Gain or loss from assets sale	-	-	-	-

Finance